Crossmark

C-reactive protein during pregnancy and in the early postpartum predicts adverse metabolic health outcomes at 1 year postpartum in women with gestational diabetes

Crossref DOI link: https://doi.org/10.1186/s12933-023-02034-9

Published Online: 2023-10-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Quansah, Dan Yedu

Horsch, Antje

Gilbert, Leah

Donath, Marc Y.

Puder, Jardena J.

,

Arhab, Amar

Bovet, Pascal

Chiolero, Arnaud

Di Bernardo, Stefano

Epure, Adina Mihaela

Younes, Sandrine Estoppey

Gilbert, Leah

Gross, Justine

Horsch, Antje

Lanzi, Stefano

Mayerat, Seyda

Mivelaz, Yvan

Puder, Jardena J.

Quansah, Dan Yedu

Rossel, Jean-Benoit

Sekarski, Nicole

Simeoni, Umberto

Stuijfzand, Bobby

Via., Yvan
Funding

Funding for this research was provided by:

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF32003B_176119, SNF32003B_176119)

University of Lausanne
License Information

Text and Data Mining valid from 2023-10-27

Version of Record valid from 2023-10-27
More Information

Article History

Received: 23 August 2023

Accepted: 15 October 2023

First Online: 27 October 2023

Declarations

:

: The study protocol was approved by the Human Research Ethics Committee of the Canton de Vaud (study number 2016–00745).

: All participants signed an informed consent.

: Authors declare no conflicts of interest.

Document is current

Any future updates will be listed below